Genovate Biotechnology Co., Ltd. (TPEX:4130)

Genovate Biotechnology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	163.88	221.6	180.03	194.17	198.44	223.21
Short-Term Investments	262.6	259.67	324.03	282.88	177.98	197.98
Trading Asset Securities	39.69	40.2	35.25	20	13	-
Cash & Short-Term Investments	466.16	521.47	539.3	497.05	389.42	421.19
Cash Growth	-11.32%	-3.31%	8.50%	27.64%	-7.54%	-7.99%
Accounts Receivable	90.41	89.06	87.87	96.13	94.39	68.68
Other Receivables	1.55	1.4	1.28	27.77	0.77	0.64
Receivables	91.96	90.46	89.15	123.89	95.16	69.33
Inventory	150.84	145.87	139.64	145.86	139.94	139.64
Prepaid Expenses	7.48	7.34	3.39	14.79	10.38	1.47
Other Current Assets	0.01	0.31	0.29	0.28	0.02	0.02
Total Current Assets	716.45	765.45	771.77	781.88	634.93	631.65
Property, Plant & Equipment	413.72	393.95	392.12	403.29	409.6	435.03
Long-Term Investments	336.17	398.55	397.28	351.6	439.52	476.6
Other Intangible Assets	3.86	3.11	4.66	0.8	1.49	2.51
Other Long-Term Assets	28.56	29.16	34.62	26.87	29.97	25.04
Total Assets	1,499	1,590	1,600	1,564	1,516	1,571
Accounts Payable	32.85	40.28	32.87	45.91	35	36.8
Accrued Expenses	26.62	37.49	29.57	35.55	29.4	31.21
Current Portion of Leases	1.14	0.86	0.67	1.25	0.74	1.23
Current Income Taxes Payable	2.21	4.39	1.37	3.27	3.4	1.94
Current Unearned Revenue	2.15	1.96	4.9	4.73	4.03	3.92
Other Current Liabilities	54.8	51.5	48.36	41.12	38.05	41.32
Total Current Liabilities	119.77	136.48	117.73	131.84	110.61	116.41
Long-Term Leases	0.95	1.73	0.02	0.59	0.09	0.83
Pension & Post-Retirement Benefits	-	2.75	13.7	21.06	25.82	27.51
Other Long-Term Liabilities	2.66	0.12	0.24	0.12	0.12	0.12
Total Liabilities	123.37	141.08	131.69	153.6	136.65	144.87
Common Stock	1,149	1,127	1,094	1,094	1,100	1,079
Additional Paid-In Capital	210.71	210.66	210.56	210.51	208.93	208.75
Retained Earnings	131.41	152.63	177.79	202.18	167.97	185.14
Treasury Stock	-25.72	-25.72	-	-	-63.03	-63.03
Comprehensive Income & Other	-89.9	-15.01	-13.34	-95.62	-35.04	16.22
Shareholders' Equity	1,375	1,449	1,469	1,411	1,379	1,426
Total Liabilities & Equity	1,499	1,590	1,600	1,564	1,516	1,571
Total Debt	2.09	2.58	0.68	1.84	0.83	2.06
Net Cash (Debt)	464.07	518.88	538.62	495.21	388.59	419.13
Net Cash Growth	-11.25%	-3.66%	8.77%	27.44%	-7.29%	-8.25%
Net Cash Per Share	4.07	4.52	4.68	4.37	3.43	3.69
Filing Date Shares Outstanding	113.75	113.75	114.91	114.91	113.33	113.33
Total Common Shares Outstanding	113.75	113.75	114.91	114.91	113.33	113.33
Working Capital	596.69	628.97	654.05	650.04	524.32	515.24
Book Value Per Share	12.09	12.74	12.78	12.28	12.17	12.58
Tangible Book Value	1,372	1,446	1,464	1,410	1,377	1,423
Tangible Book Value Per Share	12.06	12.71	12.74	12.27	12.15	12.56
Land	140.74	140.74	140.74	140.74	140.74	140.74
Buildings	288.07	285.06	282.26	281.85	283.17	291.96
Machinery	156.95	168.27	158.6	180.44	160.91	169.76
Construction In Progress	34.82	2.49	1.88	0.61	0.41	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.